Endocannabinoids and immune regulation
- 31 August 2009
- journal article
- review article
- Published by Elsevier BV in Pharmacological Research
- Vol. 60 (2), 85-92
- https://doi.org/10.1016/j.phrs.2009.03.019
Abstract
No abstract availableThis publication has 95 references indexed in Scilit:
- Cannabinoids reduce granuloma‐associated angiogenesis in rats by controlling transcription and expression of mast cell protease‐5British Journal of Pharmacology, 2008
- Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T CellsMolecular Pharmacology, 2008
- Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseasesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolismInternational Journal of Cancer, 2007
- The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of β-hexosaminidase from skin slices in vitroLife Sciences, 2006
- A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cellsBiochemical and Biophysical Research Communications, 2005
- Cannabinoid receptor-independent suppression of the superoxide generation of human neutrophils (PMN) by CP55 940, but not by anandamideLife Sciences, 2004
- Autocrine and Paracrine Regulation of Lymphocyte CB2 Receptor Expression by TGF-βBiochemical and Biophysical Research Communications, 2002
- Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cellsLife Sciences, 1995
- Inhibition of natural killer cell function by Marijuana componentsJournal of Toxicology and Environmental Health, 1987